Figure 1From: A budget impact analysis of the introduction of erythropoiesis stimulating agent subsequent entry biologics for the treatment of anemia of chronic kidney disease in Canada Tornado diagram demonstrating cost savings based on one-way sensitivity analyses of varying factors. Back to article page